Prof. Dr. Isabella Macário Ferro Cavalcanti graduated in Biomedicine from the Federal University of Pernambuco (UFPE). She has a master's degree in Therapeutic Innovation from the Post-graduate Program in Therapeutic Innovation at UFPE, and a doctorate in Biotechnology from the Post-graduate Program in Biological Sciences at UFPE. She is a specialist in Clinical Microbiology at the University of Pernambuco (UPE). She is currently an Associate Professor II at the Academic Center of Vitória at UFPE (CAV/UFPE) and a permanent member of the Post-graduate program in Biology Applied to Health (PPGBAS) and the Professional Master's Program in Biology Teaching in National Network (PROFBIO) from the same university. She was also a member of the Brazilian Society of Microbiology and the Scientific and Advisory Committee to Support Actions against COVID-19 at UFPE from 2020 to 2022. She is also head of, and a researcher in, the Clinical Microbiology Laboratory in the Keizo Asami Institute at UFPE (iLIKA/UFPE), and a research productivity grantee from CNPq level 2 (1E). She is the leader of the research group Clinical Microbiology and New Therapeutic Approaches (MicroNAT). She has experience in pharmaceutical nanotechnology, and basic and applied microbiology. Her research group is focused on developing drug delivery systems and evaluating their biological activities, as well as the phenotypic identification of bacteria with multi-drug resistance profiles and biofilm-producing behavior.